OR WAIT 15 SECS
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
Cablivi (caplacizumab-yhdp, Sanofi Genzyme)
Indications: Treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy
Contraindications: Previous severe hypersensitivity reaction to caplacizumab-yhdp or any of the excipients.